Delivery Order SPE2DR25D1017-SPE2DR26F9EBJ
- Not listed
- On January 15, 2026, the Defense Logistics Agency awarded a delivery order valued at $1,819.80 to AmerisourceBergen Drug Corp for the supply of Xcopri 50 mg tablets (30-count packages). The contract employs firm fixed-price pricing with a completion date of January 16, 2026, and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order was awarded on a fully competitive basis with no set-aside designation. AmerisourceBergen Drug Corp, a...
- The Defense Logistics Agency awarded a delivery order valued at $1,802.07 to AmerisourceBergen Drug Corp for the supply of Xcopri 200 mg tablets (30-count) on January 20, 2026, with an ultimate completion date of January 21, 2026. This firm fixed-price, non-set-aside contract will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a task order issued under AmerisourceBergen's parent company, Cencora, Inc.'s, substantial Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $5,570.08 to AmerisourceBergen Drug Corp for the supply of Xcopri 50 mg tablets (30-count) on January 9, 2026, with an ultimate completion date of January 12, 2026. This is a firm fixed-price, non-set-aside contract performed at the vendor's location in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $1,712.07 to AmerisourceBergen Drug Corp for the supply of Xcopri 100 mg tablets (30-count units) on January 20, 2026, with an ultimate completion date of January 21, 2026. This competitively awarded, non-set-aside contract utilizes firm fixed-price pricing and specifies performance at the contractor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. (which operates under the...
- The Defense Logistics Agency awarded a $1,251.04 delivery order to AmerisourceBergen Drug Corp on November 10, 2025, for the supply of Xcopri 100 mg tablets (30-count package). This is a firm fixed price, non-set-aside contract with an ultimate completion date of November 12, 2025, and represents a child delivery order under AmerisourceBergen's larger prime contract vehicle with DLA. The pharmaceutical product will be delivered to the company's facility in Conshohocken, Pennsylvania, where...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Xcopri 100 mg tablets (30-count units) with a ceiling value of $2,947.40. This is a firm fixed-price delivery order with no set-aside designation, indicating it was awarded through open competition. The contract has an ultimate completion date of July 31, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,731.30 to AmerisourceBergen Drug Corp for the supply of Xcopri 200 mg tablets (30-count packaging). This is a firm fixed-price, competitively awarded contract with no set-aside designation, with performance scheduled for completion by January 13, 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and is a major pharmaceutical distributor providing critical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,262.96 to AmerisourceBergen Drug Corp for the supply of Xcopri 100 mg tablets (30-count units) under a firm fixed-price contract. The award, issued on December 12, 2025, with completion targeted for December 15, 2025, represents a competitive, non-set-aside procurement supporting federal medical supply requirements. AmerisourceBergen will perform this delivery order from its corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,769.17 to Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) on January 26, 2026, for the supply of Xcopri 50 mg tablets in a quantity of 30 units. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of January 27, 2026. The place of performance is Conshohocken, Pennsylvania, where Amerisourcebergen maintains its corporate office. This delivery order falls under a larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 26, 2026, for the supply of Xcopri 50 mg tablets (30-count units) with a contract value of $6,812.78. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of January 27, 2026. AmerisourceBergen...
- SPE2DR25D1017Indefinite Delivery Contract
- SPE2DR25D1017-SPE2DR26F9EBJDelivery Order
On January 30, 2026, the Defense Logistics Agency (DLA) awarded a delivery order valued at $1,793.06 to AmerisourceBergen Drug Corp for the supply of Xcopri 200 mg tablets (30-count). This non-set-aside, competitively awarded contract employs firm fixed-price pricing and is scheduled for completion by February 2, 2026. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's parent company, Cencora, Inc., which holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999.00 and extending through December 31, 2031. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA's Medical Supply Chain. The company demonstrates extensive capability in fulfilling diverse pharmaceutical requirements, ranging from specialty medications and brand-name drugs to generic pharmaceuticals and medical supplies. The Xcopri delivery order represents a routine task order under the larger IDC vehicle, which enables flexible and comprehensive pharmaceutical support to military treatment facilities, the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems on a global basis.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 1/29/26 |